Scarica l'app Stockscreener
54.92
0.77%
0.42
Dopo l'orario di chiusura:
55.00
0.08
+0.15%
Uniqure N V Borsa (QURE) Ultime notizie
Will uniQure N.V. bounce back from current supportEarnings Beat & Safe Entry Zone Identification - newser.com
Will uniQure N.V. (UQ1) stock beat value stocksJuly 2025 Sentiment & Accurate Buy Signal Notifications - newser.com
uniQure N.V. stock retracement – recovery analysisDay Trade & Weekly Return Optimization Plans - newser.com
Measuring uniQure N.V.’s beta against major indices2025 Growth vs Value & Safe Entry Momentum Stock Tips - newser.com
QURE: Why Analysts See Up to 63% Upside After 250% Single-Day Pop - MarketBeat
Morgan Lewis Advises UniQure in $345 Million Public Equity Offering - Morgan Lewis
Is uniQure N.V. (UQ1) stock nearing a technical breakoutWeekly Investment Report & AI Based Buy and Sell Signals - newser.com
Visual trend scoring systems applied to uniQure N.V.Quarterly Performance Summary & High Accuracy Swing Entry Alerts - newser.com
How to build a custom watchlist for uniQure N.V.Portfolio Profit Report & Growth Oriented Trade Recommendations - newser.com
Is uniQure N.V. stock a safe investment in uncertain marketsMarket Performance Summary & Risk Controlled Swing Alerts - newser.com
Is uniQure N.V. (UQ1) stock a top dividend aristocrat candidate2025 Institutional Moves & Real-Time Volume Analysis - newser.com
Is uniQure N.V. showing signs of accumulationCEO Change & Short-Term High Return Ideas - newser.com
Is uniQure N.V. meeting your algorithmic filter criteriaJuly 2025 Recap & AI Powered Market Trend Analysis - newser.com
uniQure Completes $345 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - Global Legal Chronicle
Wells Fargo Maintains uniQure N.V. (QURE) Overweight Recommendation - Nasdaq
Wells Fargo Upgrades UniQure NV(QURE.US) to Buy Rating, Raises Target Price to $80 - 富途牛牛
uniQure (QURE) Sees Raised Price Target and Maintained Overweigh - GuruFocus
uniQure Stock Price Target Raised on Blockbuster Opportunity - AskTraders.com
Wells Fargo Maintains UniQure NV(QURE.US) With Buy Rating, Raises Target Price to $80 - 富途牛牛
United States Viral Vector Manufacturing Market Set for Strong - openPR.com
uniQure N.V. (QURE) Price Target Increased by 88.86% to 69.17 - Nasdaq
uniQure NV Hits New 52-Week High of $55.11, Surging 909.48% - Markets Mojo
uniQure N.V. (QURE) Reports Positive Phase I/II Results, Prepares FDA BLA Submission - Insider Monkey
uniQure announces pricing of upsized $300M public offering - MSN
uniQure (NASDAQ:QURE) Reaches New 52-Week HighStill a Buy? - MarketBeat
Is uniQure N.V. stock in correction or buying zoneWeekly Trade Analysis & Technical Buy Zone Confirmations - newser.com
uniQurex (QURE) Nearly Quadruples on Stellar Results for Huntington Disease Treatment - Insider Monkey
uniQure (NASDAQ:QURE) Sees Unusually-High Trading VolumeHere's What Happened - MarketBeat
uniQure completes $345 million public offering to fund gene therapy pipeline - Investing.com India
UniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares - MarketScreener
Silicon Valley - FinancialContent
What drives uniQure NV stock priceStock Price Targets & Minimize Portfolio Damage with Warnings - earlytimes.in
Research Analysts Set Expectations for uniQure Q3 Earnings - MarketBeat
uniQure FY2025 EPS Forecast Reduced by Cantor Fitzgerald - MarketBeat
StockWatch: uniQure Shares Reach Five-Year High on “Game Changing” Huntington’s Data - Genetic Engineering and Biotechnology News
uniQure (QURE) Is Up 291.6% After AMT-130’s Breakthrough Phase I/II Huntington’s Results and FDA Designations – Has The Bull Case Changed? - simplywall.st
uniQure announces $200 million proposed public offering - MSN
Why uniQure (QURE) Is Up After Positive AMT-130 Trial Results and Major New Funding Announcements - Yahoo Finance
Benzinga Bulls And Bears: Oracle, Costco, NIO — And Wall Street Snaps Its Slide - Benzinga
uniQure (QURE) Stock Soars on Huntington’s Breakthrough – Key Facts & 2025 Outlook - ts2.tech
uniQure N.V.: CFO Klemt sells $945k in shares By Investing.com - Investing.com Canada
2.68%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):